Publications

Sha Q, Galvis MLEscobar, Madaj ZB, Keaton SA, Smart LA, Edgerly YM, Anis E, Leach R, Osborne LM, Achtyes E et al..  2024.  Dysregulated placental expression of kynurenine pathway enzymes is associated with inflammation and depression in pregnancy.. Brain Behav Immun. 119:146-153.

Surkan PJ, Park S, Sheng Z, Zaidi A, Atif N, Osborne LM, Rahman A, Malik A.  2024.  Effects of a prenatal anxiety randomized controlled trial intervention on infant development in Pakistan.. Acad Pediatr.

Etyemez S, Mehta K, Tutino E, Zaidi A, Atif N, Rahman A, Malik A, Voegtline KM, Surkan PJ, Osborne LM.  2024.  The immune phenotype of perinatal anxiety in an anxiety-focused behavioral intervention program in Pakistan.. Brain Behav Immun. 120:141-150.

Osborne LM, Monk C.  2024.  Perinatal mental health: Research that moves the agenda forward.. Semin Perinatol. :151952.

Carlini SV, Osborne LM, Deligiannidis KM.  2023.  Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression.. Dialogues Clin Neurosci. 25(1):92-100.

Osborne LM, Jan RKais, Kulkarni J.  2023.  Editorial: Highlights in women's mental health 2021/22.. Front Glob Womens Health. 4:1323318.

Etyemez S, Miller KN, Voegtline KM, Özdemir İ, Standeven LR, Santovito LSpiro, Pinna G, Payne JL, Osborne LM.  2023.  Metabolites of progesterone in pregnancy: Associations with perinatal anxiety.. Psychoneuroendocrinology. 156:106327.

Riddle JN, Yau B, Baller E, Bradshaw P, Leistikow N, Ross DA, Osborne LM.  2023.  The Other Postpartum: Pregnancy Loss and Mental Illness.. Biol Psychiatry. 93(10):e31-e32.

Hannan K, Sherer ML, Osborne LM.  2023.  Vitamin D levels and anxiety symptomatology in pregnancy and the postpartum.. Arch Womens Ment Health. 26(6):857-861.

Osborne LM, Payne JL, Sherer ML, Sabunciyan S.  2022.  Altered extracellular mRNA communication in postpartum depression is associated with decreased autophagy.. Mol Psychiatry. 27(11):4526-4535.

Sherer ML, Voegtline KM, Park H-S, Miller KN, Shuffrey LC, Klein SL, Osborne LM.  2022.  The immune phenotype of perinatal anxiety.. Brain Behav Immun. 106:280-288.

Osborne LM, Gilden J, Kamperman AM, Hoogendijk WJG, Spicer J, Drexhage HA, Bergink V.  2020.  T-cell defects and postpartum depression.. Brain Behav Immun. 87:397-403.

Osborne LM, Yenokyan G, Fei K, Kraus T, Moran T, Monk C, Sperling R.  2019.  Innate immune activation and depressive and anxious symptoms across the peripartum: An exploratory study.. Psychoneuroendocrinology. 99:80-86.

Osborne LM, Betz JF, Yenokyan G, Standeven LR, Payne JL.  2019.  The Role of Allopregnanolone in Pregnancy in Predicting Postpartum Anxiety Symptoms.. Front Psychol. 10:1033.

Osborne LM, Brar A, Klein SL.  2019.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.. Brain Behav Immun. 76:7-16.

Osborne LM, Gispen F, Sanyal A, Yenokyan G, Meilman S, Payne JL.  2017.  Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study.. Psychoneuroendocrinology. 79:116-121.

Osborne LM, Monk C.  2013.  Perinatal depression--the fourth inflammatory morbidity of pregnancy? Theory and literature review. Psychoneuroendocrinology. 38(10):1929-52.